$3.00
arrow_drop_up3.44%Key Stats | |
---|---|
Open | $2.90 |
Prev. Close | $2.90 |
EPS | -110.20 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $63.75M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 2.80 | 3.00 |
52 Week Range | 1.59 | 7.97 |
Ratios | |
---|---|
EPS | -110.20 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Celularity Appoints Richard J. Berman to its Board of Directors
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing